Header cover image

Taiwanese (TAIEX) Biotech Industry Analysis

UpdatedMay 12, 2025
DataAggregated Company Financials
Companies67
  • 7D-2.1%
  • 3M-16.2%
  • 1Y0.5%
  • YTDn/a

Over the last 7 days, the Biotech industry has dropped 2.1%, driven by PharmaEssentia declining 7.4%. Over the last year, the industry has been flat overall. Looking forward, earnings are forecast to grow by 53% annually.

Industry Valuation and Performance

Has the Taiwanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 12 May 2025NT$497.0bNT$30.3b-NT$6,456,063,000.0037.4x-77x16.4x
Wed, 09 Apr 2025NT$437.7bNT$28.1b-NT$7,302,014,000.0027.7x-59.9x15.6x
Fri, 07 Mar 2025NT$545.1bNT$28.0b-NT$8,407,141,000.0033.6x-64.8x19.5x
Sun, 02 Feb 2025NT$550.6bNT$24.8b-NT$10,902,841,000.0034.9x-50.5x22.2x
Tue, 31 Dec 2024NT$509.9bNT$24.8b-NT$10,902,841,000.0034.2x-46.8x20.6x
Thu, 28 Nov 2024NT$507.5bNT$24.8b-NT$10,782,551,000.0037.7x-47.1x20.5x
Sat, 26 Oct 2024NT$545.1bNT$23.5b-NT$10,829,095,000.0039x-50.3x23.2x
Mon, 23 Sep 2024NT$579.7bNT$23.5b-NT$10,829,095,000.0035x-53.5x24.7x
Wed, 21 Aug 2024NT$569.0bNT$23.6b-NT$10,755,142,000.0034.4x-52.9x24.2x
Fri, 19 Jul 2024NT$579.6bNT$21.9b-NT$11,110,643,000.0044.6x-52.2x26.4x
Sun, 16 Jun 2024NT$513.1bNT$21.9b-NT$11,110,643,000.0042.7x-46.2x23.4x
Tue, 14 May 2024NT$454.6bNT$21.0b-NT$12,438,653,000.0034.5x-36.5x21.7x
Thu, 11 Apr 2024NT$463.3bNT$21.1b-NT$11,599,476,000.0051.7x-39.9x22x
Sat, 09 Mar 2024NT$436.2bNT$20.8b-NT$9,880,735,000.0038.8x-44.1x21x
Mon, 05 Feb 2024NT$435.3bNT$19.9b-NT$9,830,596,000.0039.3x-44.3x21.9x
Wed, 03 Jan 2024NT$473.1bNT$19.8b-NT$9,748,146,000.0039.6x-48.5x24x
Fri, 01 Dec 2023NT$485.5bNT$19.9b-NT$9,737,975,000.0043.1x-49.9x24.4x
Sun, 29 Oct 2023NT$472.4bNT$18.4b-NT$10,823,013,000.0051.5x-43.6x25.6x
Tue, 26 Sep 2023NT$482.7bNT$18.3b-NT$10,776,417,000.0043.7x-44.8x26.4x
Thu, 24 Aug 2023NT$479.5bNT$18.2b-NT$10,711,380,000.0041.9x-44.8x26.3x
Sat, 22 Jul 2023NT$481.7bNT$18.7b-NT$10,724,655,000.0046x-44.9x25.8x
Mon, 19 Jun 2023NT$481.1bNT$18.7b-NT$10,709,428,000.0042.7x-44.9x25.8x
Wed, 17 May 2023NT$487.3bNT$18.6b-NT$9,763,193,000.0043.8x-49.9x26.2x
Fri, 14 Apr 2023NT$519.7bNT$18.5b-NT$9,600,625,000.0043.2x-54.1x28.1x
Sun, 12 Mar 2023NT$510.5bNT$22.3b-NT$7,221,244,000.0037.4x-70.7x22.9x
Tue, 07 Feb 2023NT$531.0bNT$21.8b-NT$7,778,690,000.0038.7x-68.3x24.3x
Thu, 05 Jan 2023NT$494.0bNT$21.8b-NT$7,778,690,000.0036.7x-63.5x22.7x
Sat, 03 Dec 2022NT$524.3bNT$21.8b-NT$7,522,211,000.0040.3x-69.7x24x
Mon, 31 Oct 2022NT$434.1bNT$23.1b-NT$6,633,590,000.0034.3x-65.4x18.8x
Wed, 28 Sep 2022NT$565.9bNT$23.1b-NT$6,633,590,000.0040.7x-85.3x24.5x
Fri, 26 Aug 2022NT$611.3bNT$23.0b-NT$6,443,294,000.0042.2x-94.9x26.6x
Sun, 24 Jul 2022NT$545.5bNT$22.5b-NT$5,642,821,000.0030.3x-96.7x24.2x
Tue, 21 Jun 2022NT$507.0bNT$22.5b-NT$5,642,821,000.0031.1x-89.9x22.5x
Thu, 19 May 2022NT$506.3bNT$22.0b-NT$5,837,558,000.0031.3x-86.7x23x
Price to Earnings Ratio

-86.7x


Total Market Cap: NT$506.3bTotal Earnings: -NT$5,837,558,000.00Total Revenue: NT$22.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Biotech Industry Price to Earnings3Y Average -57.8x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 23.3x is higher than the industry's current PS ratio of 16.4x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 11% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Taiwanese Biotech compare with similar industries?

TW Market0.52%
Healthcare-0.54%
Biotech-2.08%
Biotech-2.08%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6550 Polaris GroupNT$42.103.8%
+NT$1.2b
-40.3%PS303.1x
4162 PharmaEngineNT$91.003.8%
+NT$474.1m
-1.7%PE7.5x
6696 Lin BioScienceNT$119.503.5%
+NT$330.7m
30.9%PB3.5x
4174 OBI PharmaNT$39.252.9%
+NT$289.3m
-35.9%PS164.7x
6617 Gongwin Biopharm HoldingsNT$100.002.0%
+NT$252.1m
-45.9%PS393.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6446

NT$499.00

PharmaEssentia

7D

-7.4%

1Y

56.2%

6875

NT$49.05

Pharmosa Biopharm

7D

-6.4%

1Y

-31.4%

4142

NT$18.55

Adimmune

7D

-2.4%

1Y

-32.3%

4726

NT$31.90

Mycenax Biotech

7D

-6.3%

1Y

-28.3%

6539

NT$85.00

DV Biomed

7D

13.8%

1Y

-35.5%

6617

NT$100.00

Gongwin Biopharm Holdings

7D

2.0%

1Y

-45.9%

6657

NT$63.50

Energenesis BiomedicalLTD

7D

4.6%

1Y

17.4%

6541

NT$56.90

Tanvex BioPharma

7D

-2.9%

1Y

30.7%

4174

NT$39.25

OBI Pharma

7D

2.9%

1Y

-35.9%

6547

NT$49.15

Medigen Vaccine Biologics

7D

-5.7%

1Y

-7.1%

4147

NT$79.00

TaiMed Biologics

7D

-1.0%

1Y

-8.7%

6945

NT$52.60

AP Biosciences

7D

4.6%

1Y

-11.6%

4162

NT$91.00

PharmaEngine

7D

3.8%

1Y

-1.7%

4728

NT$453.50

Sunmax Biotechnology

7D

-7.6%

1Y

87.4%

6550

NT$42.10

Polaris Group

7D

3.8%

1Y

-40.3%

6696

NT$119.50

Lin BioScience

7D

3.5%

1Y

30.9%